A leader from the healthcare technology company discusses the conflict’s impact on the region and beyond and the need to better guard against interruptions.
The company’s analysis of clinical research activity in the region shows the conflict will have long-lasting effects that reach beyond the country’s borders.
CRO PopsiCube opens strategic Russian affiliate to further its international expansion of clinical trial management and digital services.
Marken has opened a new customer solutions center at its Moscow depot and will announce additional service offerings in the coming weeks.
Hermes Pharma has received authorisation to make drugs for the Russian market from facilities in Austria and Germany.
Slovakian contract manufacturer Saneca says the opportunity to tap the Russian market is huge despite protectionist policies and changing GMP inspection requirements.
Marken’s Moscow-based depot has been granted a new pharmaceutical license from the Russian Federation, further extending the company’s capabilities in the area.
Vladimir Putin says support from Russian business community is needed to help achieve the domestic drug manufacturing goals set out in his Pharma 2020 policy.
Lupin is set to acquire Russian generics maker Biocom, adding a GMP compliant facility and gaining access to the local market.
Big Pharma firms’ exposure to Russia’s volatile rouble is limited and planned manufacturing investments will go ahead according to observers.
Several international CMOs will establish themselves in Russia over the next few years as pharma looks to satisfy the country's manufacturing policies, the CEO of R-Pharm predicts.
Marken on Wednesday announced its pharma depot network is expanding to Russia to meet the growing needs of clients looking to store materials for clinical trials there and in Eastern Europe.
Aspen Pharma saw its revenue increase over the past year by almost 30% and is now looking to further expand its manufacturing capabilities.
Pharma may be "wary of making big investments" in the protected Russian market leaving an opportunity for local CMOs, according to an industry expert.
International GMP standard facilities and six biopharma centres will lead Russia’s initiative in implementing its Pharma 2020 policy, according to statements at this year’s BIO International Convention.
Bayer Healthcare has partnered with Medsintez in a deal designed to allow the German firm to make and sell drugs in Russia.
Takeda has opened a new $96m (€75m) pharma facility in Russia as part of its bid to “outgrow” the already thriving local market.
Oncology clinical trials take 50 per cent longer to go from protocol approval to randomisation of the last subject, a report found.
Quintiles is driving its clinical development services in the Russian Federation through a new alliance with Russian Venture Company (RVC).
Detailed market knowledge and an experienced CMO are still critical to successfully developing a biopharmaceutical or biosimilar according to Cobra Biologics.
Decline in Russian trial approvals slows in Q3
New data suggests the Russian MoH is getting faster at reviewing and approving clinical trials.
ViiV teams with Russian manufacturer
ViiV, GSK and Pfizer’s HIV joint venture, has partnered with Russia’s JSC Binnopharm to boost manufacturing capacity in the country.
Russia has the potential to dominate API production, say PMR
Market analysts PMR have launched a new paper highlighting the potential for API production in Russia, Ukraine and the Baltics.
Novartis starts work on Russian manufacturing plant
Novartis has started work on a manufacturing plant in St Petersburg in the first stage of a $500m investment in the Russian pharmaceutical industry.
Schott targets growth in Russia
Primary packaging maker Schott has joined the growing list of drug industry companies seeking to tap Russian government demand for increased domestic manufacturing.
Dr Reddy’s aims at Russian growth with R-Pharma accord
Indian drugmaker Dr Reddy’s Laboratories has formed a manufacturing partnership with R-Pharm in a bid to strengthen its position in Russia’s fast-growing drug market.
Novartis strikes Russian allegiance; builds manufacturing plant
Novartis will build a new $500m (€379.9m) pharmaceutical manufacturing plant in St Petersburg, Russia after signing a Memorandum of Understanding (MoU) with the city.
PPD expands Russian presence with Novosibirsk office
US CRO PPD has opened a new office in Novosibirsk, Russia to provide clinical monitoring services for its Phase II-IV trial business.
IAG raises $52m to establish Russian preclinical GLP CRO
Investors are funding the creation of a RUB1.6bn ($52m), 10,000 sq m preclinical Russian CRO to fill the gap in the nation’s development chain and undercut western prices by 40 per cent.
USP forges stronger links with Ukraine and Russia
The USP is strengthening links with Eastern Europe and Russia by agreeing to share quality standards with Ukraine and offering training courses in Moscow.
Russia, the Ukraine and Belarus have emerged as destinations for clinical studies and now offer “enormous” potential according to US-based CRO ClinStar.
Gerreshemier sets up Moscow sales office
German glassmaker Gerresheimer has set up a new sales office in Russia and says growth in country’s drug packaging market is strategically important.
Schott: Russian plant operational by year end
Schott says its new Russian packaging plant will help meet demand of growing local pharmaceutical market.
Sanofi plans to join Russian manufacturing project
Sanofi-Aventis plans to participate with a Russian state-owned corporation in a project to attract innovative drug manufacturers to the country, using its insulin facility as a pilot initiative.
ChemDiv’s Russian arm wins Viriom HIV research contract
ChemDiv’s subsidiary Chemical Diversity Research Institute (CDRI), based in Moscow, Russia, will carry out development work on a range of HIV antivirals on behalf of new drugmaker Viriom.
Nycomed plans €75m Russian plant; may up €4.5bn bid for Solvay
Late last week Swiss drugmaker Solvay confirmed its plan to invest up to $75m (€51m) to build a new manufacturing plant in Yaroslavl, Russia.
LGC makes “next logical step” and brings lab services to Russia
LGC Standards has made the “next logical step” in its “concerted effort” to expand internationally by opening an office in St Petersburg, Russia, less than six months after it moved into China.
Number of trials registered with Russia’s RZN falls 17% in Q2
The number of registered clinical trials in Russia slipped in Q2, with the country attracting fewer international sponsors and regulatory inspections than in pervious years.
Nycomed to expand manufacturing operations in Russia
Swiss drugmaker Nycomed will invest $84m (€60m) in a pharmaceutical manufacturing plant in Russia, boosting its presence in the country.
USP effort to raise global standards reaches Russia
The USP and Roszdravnadzor, a Russian public health body, are collaborating in an attempt to improve the standards of ingredients and finished products and reduce the availability of counterfeits.
Russia initiates most clinical trials in Q1
Russia has witnessed a drop in generating new business activity on
the clinical trials scene over the past year, but has been
increasing its own activity in this field.
Russia's clinical scene to remain 'heated'
The pharmaceutical industry is expected to show "continuing high
interest" in conducting clinical trials in Russia, reveals a new
Chiltern makes latest CRO move into Russia
Chiltern has become the latest in a growing number of contract
research organisations (CROs) to establish a foothold within the
clinical sleeping giant that is Russia.
Schott takes aim at Russia
Pharmaceutical packaging specialist Schott has announced plans to
head to Russia and establish its first pharma production site in
Russia's clinical biz showing signs of recovery after biologics ban
Russia's clinical trials industry appears to be making a gradual
recovery from a setback earlier this year when the government
imposed an unexpected ban on biologic exports.
Mega deal creates largest pharma player in CEE
Hungarian pharma Gedeon Richter has announced plans to combine with
Polish firm Polpharma to create a major presence in Central Eastern
Europe (CEE) through a share deal worth HUF231bn ($1.3bn).
US-Russian CRO pact inked
Russian contract research organisation (CRO) Synergy Research Group
has hooked up with a US-based CRO in a bid to expand its services
to North America.
Biologicals ban could halt the rush on Russia for clinical trials
Just as the clinical trials sector in Russia is
starting to take off, the industry has been dealt a severe
blow with the sudden and indefinite banning of biological sample
Hesperion turns to Russia to tackle large trials
Hesperion has opened a Russian arm of its contract research
business in a bid to 'increase its attractiveness' to clinical
trial sponsors requiring large patient populations.
Russia gets tough with drug counterfeiters
In Russia, the Health Ministry suspended the licences of 321
companies manufacturing or trading in counterfeit medicines last
year, and a further 200 may also lose their licences following
ongoing investigations, according to the...